4.5 Article

A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Treatment of metastatic breast cancer: second line and beyond

H. Roche et al.

ANNALS OF ONCOLOGY (2011)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Review Oncology

Cancer stem cells: problems for therapy?

Malcolm R. Alison et al.

JOURNAL OF PATHOLOGY (2011)

Article Gastroenterology & Hepatology

CD24 is Upregulated in Inflammatory Bowel Disease and Stimulates Cell Motility and Colony Formation

Mohamed A. H. Ahmed et al.

INFLAMMATORY BOWEL DISEASES (2010)

Article Medicine, Research & Experimental

Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

Glen Kristiansen et al.

LABORATORY INVESTIGATION (2010)

Article Oncology

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

Emad A. Rakha et al.

CLINICAL CANCER RESEARCH (2009)

Review Cell Biology

Cancer stem cells: implications for the progression and treatment of metastatic disease

A. K. Croker et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)

Article Oncology

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

Xiaoxian Li et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Article Medicine, General & Internal

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

Rui Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Multidisciplinary Sciences

Prospective identification of tumorigenic breast cancer cells

M Al-Hajj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)